Project Details
| Acronym | PAGANINI |
|---|---|
| Status | Not started |
Randomized, double-blind, parallel group, phase 2b dose-finding, efficacy and safety study of 12-week twice daily oral administration of BAY 1817080 compared to placebo in the treatment of refractory and/or unexplained chronic cough (RUCC)
- Ing, Alvin (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Saghaie, Tajalli (Associate Investigator)
- Rai, Meenal (Other)
Project: Research